2[2]Puavilai G,Chanprasertyotin S,Sriphrapradaeng.A.Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance:1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA).1998 WHO consueation criteria,and 1985 WHO criteria.World Health Organization[J],Diabetes Res Clin Pract,1999,44(1):21～26.
3[3]Kuzuya T,Nakagawa S,Satoh J,et al.Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus[J].Diabetes Res Clin Pract,2002,55(1):65～85.
4[4]American Diabetes Association.Report of the expert Committee on the Diagnosis and Classification of Diabetes Mellitus[J].Diabetes Care,1997,20:1183.
5[5]Herdzik E,Safranow K,Ciechanowski K,et al.Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance E[J].Pol Merkur Lekarski,2002,13(76):316.
7[7]Rahlenbeck Sl.Monitoring diabetic control in developing countries:a review of glycated hemoglobin and fructosamine assays[J].Trop Doct,1998,28(1):9.
8[8]Klonof DC.Serum fructosamine as a screening teat for type 2 diabetes[J].Diabetes Technol Ther,2000,2(4):537.
9[9]Lindsey CC,Carter AW,Mangum S,et al.A prospective,randomized,multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care[J].Diabetes Technol Ther,2004,6(3):370.
